PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | -80.0% | 6,617 | -33.9% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 10,017 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | +150.0% | 10,017 | +53.7% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 6,517 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | +150.0% | 6,517 | +18.1% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 5,517 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 5,517 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 5,517 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | -25.0% | 5,517 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -50.0% | 5,517 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | – | 5,517 | +967.1% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 517 | -68.0% | 0.00% | – |
| Q3 2016 | $1,000 | -66.7% | 1,617 | -62.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 4,253 | +24.7% | 0.00% | – |
| Q1 2016 | $2,000 | -66.7% | 3,411 | -42.1% | 0.00% | – |
| Q4 2015 | $6,000 | +500.0% | 5,894 | +559.3% | 0.00% | – |
| Q3 2015 | $1,000 | -96.2% | 894 | -93.4% | 0.00% | – |
| Q2 2015 | $26,000 | -42.2% | 13,494 | -46.2% | 0.00% | – |
| Q1 2015 | $45,000 | -8.2% | 25,061 | -6.0% | 0.00% | – |
| Q4 2014 | $49,000 | -65.7% | 26,670 | -54.9% | 0.00% | – |
| Q3 2014 | $143,000 | -65.2% | 59,184 | -47.4% | 0.00% | – |
| Q2 2014 | $411,000 | +234.1% | 112,570 | +255.1% | 0.00% | – |
| Q4 2013 | $123,000 | -54.4% | 31,697 | -46.8% | 0.00% | – |
| Q3 2013 | $270,000 | +592.3% | 59,606 | +660.6% | 0.00% | – |
| Q2 2013 | $39,000 | – | 7,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|